Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.

Looking back on consumer discretionary - education services stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Covista (NYSE:CVSA) and its peers.

Beck's sale reduces direct holdings by 14%, yet he retains a $4 million stake.

Shares of vocational education company Covista (NYSE:CVSA) jumped 13.3% in the afternoon session after second-quarter 2026 revenue and adjusted earnings both cleared Wall Street estimates. Covista paired mid-single-digit-plus revenue growth with a double-digit EPS beat and wider operating margins, then layered on full-year adjusted earnings guidance above consensus. Revenue rose 9.7% to $501.4 million, while adjusted EPS of $2.09 beat forecasts by about 10%, a combination that usually implies bo

CVSA posts double-digit profit growth, record Walden enrollment and raises fiscal 2027 targets as strong execution continued across all three segments.

Company exceeds fiscal 2026 guidance with 9.3% revenue growth, expands margins, and returns $238 million to shareholders while positioning for continued expansion in fiscal 2027.

Covista (CVSA) delivered earnings and revenue surprises of +10.00% and +3.38%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Vocational education company Covista (NYSE:CVSA) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 9.7% year on year to $501.4 million. The company expects the full year’s revenue to be around $2.07 billion, close to analysts’ estimates. Its non-GAAP profit of $2.09 per share was 10.4% above analysts’ consensus estimates.

CVSA heads into Q4 earnings with rising enrollment and healthcare education demand expected to support revenue and profit growth.

Covista Inc. recently expanded its leadership bench, appointing Scott Liles as Chief Strategy and Performance Officer and President, Medical and Veterinary, while also creating a Performance Acceleration Office reporting to CEO Steve Beard. The company further broadened its governance and sector expertise by adding technology and fintech veteran Emily C. Chiu and veterinary and healthcare operator Leslie Storms to its Board of Directors. Next, we’ll examine how the new Performance...

Value investing has produced some of the world’s most famous investing billionaires, including Warren Buffett, David Einhorn, and Seth Klarman, who built their fortunes by purchasing wonderful businesses at reasonable prices. But these hidden gems are few and far between - many stocks that appear cheap often stay that way because they face structural issues.

Laureate Education (LAUR) delivered earnings and revenue surprises of +4.17% and +1.29%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies — as Jeff Bezos said, “Your margin is my opportunity”.